DENTSPLY SIRONA Inc. (XRAY): 10-Q filed May 8, 2025

AI analysis of the 10-Q that DENTSPLY SIRONA Inc. filed with the U.S. SEC on May 8, 2025, grounded in the primary-source EDGAR filing.

• Derivative Losses Signal Rising Hedging Costs: Accumulated losses from non-designated derivatives indicate the company is absorbing greater financial volatility, reflecting increased complexity in risk management that may pressure near-term earnings.

• Foreign Currency Exposure Remains Material: Significant FX translation adjustments across quarters underscore vulnerability to international market fluctuations, with potential margin impact on the company's diversified geographic footprint.

• Four-Segment Portfolio Shows Interdependencies: Connected Technology, Essential Dental, Orthodontic/Implant, and Wellspect Healthcare segments exhibit performance correlation, limiting portfolio diversification benefits and concentrating business risk.

• Cautious Management Posture: Neutral-to-cautious sentiment suggests management is preparing for headwinds; investors should monitor hedging intensity and FX exposure as leading indicators of confidence levels.

Filing analysis — key questions

Answers are generated from this SEC filing and StockHuntr's analysis. Not investment advice.

What does DENTSPLY SIRONA Inc. (XRAY)'s 10-Q filed May 8, 2025 say?

Quarterly Financial Results for Q1 2025 - Contains consolidated financial statements including balance sheet as of March 31, 2025, income statement for the three months ended March 31, 2025, and comparative periods from 2024, along with cash flow statements and statements of stockholders' equity Business Operations and Segment Performance - Reports on the dental equipment and supplies company's…

Is XRAY's 10-Q bullish or bearish?

Our analysis rates this filing CAUTIOUS. DENTSPLY SIRONA presents an elevated but manageable risk profile typical of a diversified medical device manufacturer with significant international operations. The concern level of 5.8/10 reflects three material new risks centered on foreign exchange…

How concerning is XRAY's latest 10-Q?

Concern level: ELEVATED (5.8/10). Key factors: Three new high-severity risks identified with average severity of 5.7/10: Foreign Currency Exchange Rate Volatility (6/10), Derivative Financial Instruments Exposure (5/10), and Segment Performance Concentration Risk (6/10); Material foreign currency translation exposure across US, Europe, and Rest of World segments creating earnings volatility;…

What are the main risks flagged in XRAY's 10-Q?

Notable risk changes: Q1 2025 filing reveals active derivative hedging program with accumulated losses from non-designated derivatives, indicating increased financial risk management complexity; International operations create material foreign currency translation adjustments visible in comprehensive income statements across multiple quarters; Company maintains four distinct operating segments (Connected Technology,…

Did XRAY beat or miss expectations in this filing?

No earnings surprise data found in provided excerpt.

About this analysis

Primary source:
View this 10-Q on SEC EDGAR
Additional data:
Yahoo Finance (market data)
Method:
StockHuntr analyzes filings with AI — see our methodology.
Analysis as of:
May 8, 2025
Published by:
StockHuntr

For research and education only. Nothing here is investment advice.

📄

Fetching Filing from SEC

Downloading filing HTML from SEC.gov...

15% Complete
1
Fetch filing from SEC
2
Parse document sections
3
Fetch prior filing
4
Analyze risk factors
5
Analyze management sentiment
6
Extract financial metrics
7
Compare to analyst consensus
8
Run ML prediction model
9
Finalize analysis

Note: Analysis typically takes 30-60 seconds. We're fetching real SEC filing data and running AI analysis on the actual content.